148,77 €
1,33 % heute
L&S, 16. September, 22:25 Uhr
ISIN
US4781601046
Symbol
JNJ
Berichte

Johnson & Johnson Aktie News

Neutral
MarketBeat
11 Minuten alt
Stocks are rallying on the expectation that the Federal Reserve will cut interest rates by 25 basis points in September. That should be positive for corporate earnings.
Neutral
PRNewsWire
ein Tag alt
21 abstracts from across the Company's portfolio highlight clinical and real-world data on major depressive disorder, treatment-resistant depression and schizophrenia New Phase 3 data demonstrate the safety and efficacy of adjunctive seltorexant compared to quetiapine XR in major depressive disorder with insomnia symptoms TITUSVILLE, N.J. , Sept. 15, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE...
Positiv
The Motley Fool
ein Tag alt
How much would your $1,000 investment be worth if you'd bought Johnson & Johnson (JNJ -0.23%) five years ago? It would be worth $1,359.
Negativ
Market Watch
4 Tage alt
Shares of companies that make COVID vaccines sank Friday, after a report raised fears that Trump administration health officials will blame the vaccines for some child deaths.
Neutral
Accesswire
4 Tage alt
WATERLOO, ON / ACCESS Newswire / September 12, 2025 / J&J Painting, a trusted name in residential and commercial painting services, has been recognized with the 2026 Consumer Choice Award in the Painting Contractor category for Waterloo. Known for its commitment to quality, precision, and outstanding customer service, the company continues to raise the bar for professional painting in the region.
Neutral
GlobeNewsWire
5 Tage alt
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor. 1
Neutral
Seeking Alpha
6 Tage alt
Johnson & Johnson (NYSE:JNJ ) Morgan Stanley 23rd Annual Global Healthcare Conference September 10, 2025 11:30 AM EDT Company Participants Joaquin Duato - CEO & Chairman John Reed - Executive Vice President of Innovative Medicine, R&D Conference Call Participants Terence Flynn - Morgan Stanley, Research Division Presentation Terence Flynn Equity Analyst Great. Thanks for joining us, everybody.
Negativ
Barrons
6 Tage alt
The effort falls well short of banning the ads outright, but could dent sales.
Mehr News anzeigen

Kostenlos registrieren

aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.

Die Apple Aktie im Überblick mit Charts, aktuellen Kennzahlen, Nachrichten und Aktienanalysen.
Die besten Dividenden-Aktien in der Dividenden-Topscorer-Liste.
Aktienanalysen der besten Aktien weltweit.
Jetzt Vermögen aufbauen